Apellis Pharmaceuticals, Inc. (BIT:1APLS)

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	358.39	411.29	351.19	551.8	640.19	565.78
Short-Term Investments	-	4.85	4.35	6.51	61.04	311.87
Cash & Short-Term Investments	358.39	416.14	355.54	558.31	701.23	877.65
Cash Growth	7.45%	17.04%	-36.32%	-20.38%	-20.10%	149.34%
Accounts Receivable	235.25	271.72	224.5	29.17	80.1	25
Other Receivables	-	-	-	8.71	-	-
Receivables	235.25	271.72	224.5	37.88	80.1	25
Inventory	82.47	82.48	162.66	99.7	24	-
Prepaid Expenses	37.1	9.51	8.59	7.18	5.17	3.4
Restricted Cash	1.43	1.32	1.11	1.27	1.56	1.27
Other Current Assets	13.07	7.78	13.93	15.18	11.98	9.88
Total Current Assets	727.72	788.95	766.33	719.52	824.05	917.19
Property, Plant & Equipment	17.77	19.04	21.09	24.9	26.08	24.52
Long-Term Accounts Receivable	-	-	-	15	30	18
Other Long-Term Assets	61.8	77.06	1.31	0.8	1.64	0.86
Total Assets	807.29	885.05	788.73	760.22	881.77	960.57
Accounts Payable	55.29	38.57	37.52	37.34	16.91	8.48
Accrued Expenses	116.15	140.18	127.81	95.14	103.24	111.94
Current Portion of Leases	6.94	6.75	6.44	5.63	4.12	3.69
Other Current Liabilities	-	-	75.83	29.5	7.58	4.23
Total Current Liabilities	178.38	185.51	247.59	167.61	131.85	128.33
Long-Term Debt	453.42	452.83	93.03	92.74	189.02	358.83
Long-Term Leases	9.19	10.2	11.45	14.35	17.08	15.22
Other Long-Term Liabilities	2.08	7.97	242.13	315.65	345.15	253.64
Total Liabilities	643.07	656.51	594.21	590.35	683.1	756.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,295	3,267	3,036	2,480	1,857	1,131
Retained Earnings	-3,128	-3,035	-2,837	-2,309	-1,657	-926.35
Comprehensive Income & Other	-3.05	-3.31	-3.54	-0.88	-2.09	-0.12
Total Common Equity	164.22	228.54	194.52	169.87	198.66	204.56
Shareholders' Equity	164.22	228.54	194.52	169.87	198.66	204.56
Total Liabilities & Equity	807.29	885.05	788.73	760.22	881.77	960.57
Total Debt	469.55	469.78	110.93	112.71	210.22	377.73
Net Cash (Debt)	-111.16	-53.65	244.61	445.59	491.01	499.92
Net Cash Growth	-	-	-45.10%	-9.25%	-1.78%	156.43%
Net Cash Per Share	-0.89	-0.43	2.06	4.20	5.82	6.65
Filing Date Shares Outstanding	125.66	125.52	120.58	111.29	97.73	80.38
Total Common Shares Outstanding	125.66	124.5	119.56	110.77	97.52	76.13
Working Capital	549.34	603.45	518.74	551.91	692.2	788.87
Book Value Per Share	1.31	1.84	1.63	1.53	2.04	2.69
Tangible Book Value	164.22	228.54	194.52	169.87	198.66	204.56
Tangible Book Value Per Share	1.31	1.84	1.63	1.53	2.04	2.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.